Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

NCT03661320

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Local Institution - 0022 Tucson, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Local Institution - 0021 Littleton, Colorado, United States
  • Local Institution - 0036 Pensacola, Florida, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

NCT01038778

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

NCT07511517

Conditions
Carcinoma, Carcinoma, Transitional Cell, Bladder, Female Urogenital Diseases, +15 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Akershus University Hospital (Ahus) Lørenskog, Norway
  • Oslo University Hospital - Aker Oslo, Norway
  • University Hospital of North Norway (UNN) Tromsø, Norway
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

NCT04794699

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lung Diseases, +14 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

NCT06099782

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • Russell Medical ( Site 0160) Alexander City, Alabama, United States
  • Alaska Oncology and Hematology ( Site 0121) Anchorage, Alaska, United States
  • Highlands Oncology Group-Research Department ( Site 0133) Springdale, Arkansas, United States
  • Marin Cancer Care ( Site 0148) Greenbrae, California, United States
View all 45 locations
View Trial Details

Related conditions